A good practice guide to the administration of substances and removal of blood, including routes and volumes

被引:1026
作者
Diehl, KH
Hull, R
Morton, D
Pfister, R
Rabemampianina, Y
Smith, D
Vidal, JM
van de Vorstenbosch, C
机构
[1] AstraZeneca, Toxicol, R&D Charnwood, Loughborough LE11 5RH, Leics, England
[2] Aventis, D-35001 Marburg, Germany
[3] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
[4] Univ Birmingham, Sch Med, Birmingham B15 2TT, W Midlands, England
[5] Novartis Pharma AG, CH-4002 Basel, Switzerland
[6] Pfizer, Ctr Rech, Etablissement Amboise, ZI Poce Sur Cisse, F-37401 Amboise, France
[7] Aventis, F-95235 Romainville, France
[8] NV Organon, NL-5340 BH Oss, Netherlands
关键词
blood volumes; blood removal; administration substances; laboratory animals; refinement;
D O I
10.1002/jat.727
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
This article is the result of an initiative between the European Federation of Pharmaceutical Industries Associations (EFPIA) and the European Centre for the Validation of Alternative Methods (ECVAM). Its objectives are to provide the researcher in the safety evaluation laboratory with an up-to-date, easy-to-use set of data sheets to aid in the study design process whilst at the same time affording maximum welfare considerations to the experimental animals. Although this article is targeted at researchers in the European Pharmaceutical Industry, it is considered that the principles underpinning the data sets and refinement proposals are equally applicable to all those who use these techniques on animals in their research, whether in research institutes, universities or other sectors of industry. The implications of this article may lead to discussion with regulators, such as those responsible for pharmacopoeial testing. There are numerous publications dealing with the administration of test substances and the removal of blood samples, and many laboratories also have their own 'in-house' guidelines that have been developed by custom and practice over many Sears. Within European Union Directive 86/609EEC(1) we have an obligation to refine experiments to cause the minimum amount of stress, We hope that this article will provide background data useful to those responsible for protocol design and review. This guide is based on peer-reviewed publications whenever possible, but where this is not possible we have used 'in-house' data and the experience of those on the working party (as well as helpful comments submitted by the industry) for a final opinion. The guide also addresses the continuing need to refine the techniques associated with the administration of substances and the withdrawal of blood, and suggests ways of doing so. Data-sharing between laboratories should be encouraged to avoid duplication of animal work, as a cll as sharing practical skills concerning animal welfare and scientific problems caused by 'overdosing' in some way or another, The recommendations in this guide refer to the 'normal' animal, and special consideration is needed, for instance, during pregnancy and lactation. Interpretation of studies may be confounded when large volumes are administered or excessive sampling employed, particularly if anaesthetics are used. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 56 条
  • [1] Altman P. L., 1974, BIOL DATA BOOK
  • [2] [Anonymous], 1993, Lab Anim, V27, P1
  • [3] [Anonymous], 1998, HDB LAB ANIMAL MANAG
  • [4] [Anonymous], 1986, OFF J EUR COMMUN, V29, pL358
  • [5] A NEW METHOD FOR MEASURING THE BLOOD-VOLUME OF THE RAT USING (113M)INDIUM AS A TRACER
    ARGENT, NB
    LILES, J
    RODHAM, D
    CLAYTON, CB
    WILKINSON, R
    BAYLIS, PH
    [J]. LABORATORY ANIMALS, 1994, 28 (02) : 172 - 175
  • [6] CONTINUOUS DEEP INTRAVENOUS-INFUSION IN RAT EMBRYOTOXICITY STUDIES - THE EFFECTS OF INFUSION VOLUME AND 2 DIFFERENT INFUSION FLUIDS ON PREGNANCY
    BARROW, PC
    HERITIER, B
    [J]. TOXICOLOGY METHODS, 1995, 5 (01): : 61 - 67
  • [7] BEYNEN C, 1988, NEW DEV BIOSCIENCES, P431
  • [8] CALLAHAN RJ, 1995, NUCL MED, V36, P157
  • [9] CARVALHO JS, 1989, J CARDIOVASC PHARM, V13, P603
  • [10] CONTINUOUS INTRAVENOUS-INFUSION IN THE UNRESTRAINED RAT - PROCEDURES AND RESULTS
    CAVE, DA
    SCHOENMAKERS, ACM
    VANWIJK, HJ
    ENNINGA, IC
    VANDERHOEVEN, JCM
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1995, 14 (02) : 192 - 200